Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

3.73
Delayed Data
As of Feb 23
 +0.03 / +0.81%
Today’s Change
2.14
Today|||52-Week Range
4.71
-3.87%
Year-to-Date
No recent news for Rigel Pharmaceuticals Inc.

Today’s Trading

Previous close3.70
Today’s open3.75
Day’s range3.62 - 3.78
Volume612,942
Average volume (3 months)1,373,115
Market cap$542.0M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-25.86%
Earnings growth (this year)+22.47%
Earnings growth (next 5 years)+61.00%
Revenue growth (last year)-29.46%
P/E ratioNM
Price/Sales11.02
Price/Book6.67

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc+0.21+4.33%
NVAXNovavax Inc-0.06-2.51%
EDGEEdge Therapeutics In...+0.22+1.42%
BTXBioTime Inc+0.11+4.18%
Data as of 8:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$20.4M
Annual profit (last year)-$69.2M
Net profit margin-339.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Raul R. Rodriguez
Chief Medical Officer &
Executive Vice President
Anne-Marie S. Duliege
Corporate headquarters
South San Francisco, California

Forecasts